NCT05770934

Brief Summary

This trial will investigate the effectiveness of applying low-load blood flow restricted exercise 12 months after receiving a total knee replacement to achieve a functional capacity-level similar to healthy peers. Participants will be allocated to either an exercise group performing a sit-to-stand exercise 4/weekly with concurrent partial restriction of the blood flow to the limbs or a usual care.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 24, 2021

Completed
1.7 years until next milestone

First Posted

Study publicly available on registry

March 16, 2023

Completed
27 days until next milestone

Study Start

First participant enrolled

April 12, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2024

Completed
Last Updated

September 23, 2024

Status Verified

June 1, 2024

Enrollment Period

1.4 years

First QC Date

June 24, 2021

Last Update Submit

September 20, 2024

Conditions

Keywords

RehabilitationBlood flow restriction exerciseTotal knee replacementFunctional Capacity

Outcome Measures

Primary Outcomes (2)

  • 30-seconds chair stand test (30-CST)

    The 30s-CST measures the number of sit-to-stand repetitions completed within 30 seconds. Patients will be instructed to perform a sit-to-stand movement starting from a seated position (seat height 43 cm without armrests) having the feet placed flat on the floor shoulder width apart, and arms crossed on chest to a standing position (hip and knee joints fully extended) repeated as many times as possible for 30 seconds

    1 year after surgery

  • Change in 30-seconds chair stand test (30-CST)

    The 30s-CST measures the number of sit-to-stand repetitions completed within 30 seconds. Patients will be instructed to perform a sit-to-stand movement starting from a seated position (seat height 43 cm without armrests) having the feet placed flat on the floor shoulder width apart, and arms crossed on chest to a standing position (hip and knee joints fully extended) repeated as many times as possible for 30 seconds

    15 months after surgery

Secondary Outcomes (17)

  • Timed Up & Go (TUG)

    1 yeay after surgery

  • Timed Up & Go (TUG)

    15 months after surgery

  • 4x10 meter fast-paced walk test (40m-FWT)

    1 year after surgery

  • 4x10 meter fast-paced walk test (40m-FWT)

    15 months after surgery

  • Isometric knee extensor strength

    1 year after surgery

  • +12 more secondary outcomes

Study Arms (2)

home-based BFRE

EXPERIMENTAL

Patients in the home-based BFRE group will be carefully instructed in how to perform the exercise program with four weekly sessions for 12 weeks (48 training sessions within an 84-day period). Each session will consist of one lower-limb resistance training exercise: sit-to-stand from a \~43 cm high chair. The exercise will consist of four rounds interspaced by a 30-seconds rest pause. The first, second, and third round will consist of 30, 15, 15 repetitions, while the fourth round will be performed until volitional fatigue. The patients will be instructed to perform both the eccentric and concentric contractions at a steady 2-sec pace with, preferably, no time for relaxation in the transition from eccentric to concentric phase (i.e. the bottom is only "kissing" the chair before reversing the movement upwards). When a patient can perform more than 25 repetitions in the last round, they are encouraged to add external resistance corresponding to around 5 kg.

Other: Blood flow restricted low-load resistance exercise

Control Group

NO INTERVENTION

Patients in the control group will performed the same tests 12 months after surgery and 15 months after surgery as the intervention home-based BFRE group.

Interventions

Blood flow restricted low-load resistance exercise

home-based BFRE

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients included in the EXknee project (Efficacy of low-load blood flow restricted resistance EXercise in patients with Knee osteoarthritis scheduled for total knee replacement (EXKnee) Jorgensen et al. 2020)

You may not qualify if:

  • Severe cardiovascular diseases (New York Heart Association class III and IIII), -
  • previous stroke incident, thrombosis incident
  • Traumatic nerve injury in affected limb
  • Unregulated hypertension (Systolic ≥180 or diastolic ≥110 mmHg)
  • Spinal cord injury
  • Cancer diagnosis and currently undergoing chemo-, immuno-, or radiotherapy
  • Inadequacy in written and spoken Danish
  • living more than 45 minutes from either Horsens Regional Hospital or Silkeborg Regional Hospital.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Regional Hospital Horsens

Horsens, Horsens, 8700, Denmark

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 24, 2021

First Posted

March 16, 2023

Study Start

April 12, 2023

Primary Completion

August 30, 2024

Study Completion

August 30, 2024

Last Updated

September 23, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will share

Regional Hospital Horsens is responsible for handling all personal data provided by both sites in accordance to the Clinical Trial Agreement and the EU General Data Protection Regulation (GDPR)

Locations